Pragmatic clinical trials (ePCTs) advance research on Alzheimer’s disease and related dementias (AD/ADRD) in real world contexts; however, health equity issues have not yet been fully considered, assessed, or integrated into ePCT designs. Health disparities populations may not be well represented in ePCTs without special efforts to identify and successfully recruit sites of care that serve larger numbers of these populations. The National Institute on Aging (NIA) Imbedded Pragmatic Alzheimer’s disease (AD) and AD Related Dementias (AD/ADRD) Clinical Trials (IMPACT) Collaboratory’s Health Equity Team (HET) will contribute to the overall mission of the NIA IMPACT Collaboratory by developing and implementing strategies to address health equity in the conduct of ePCTs to ensure that the Collaboratory is a national resource for all Americans with dementia. As a first step toward meeting these goals, this talk highlights unique challenges related to health equity in the conduct of ePCTs.
April 16, 2020
- Understand the role and objectives of the Health Equity Team in the IMPACT Collaboratory.
- Describe the conceptualization of health equity as it relates to ePCTs design.
- Understand and describe important health equity considerations in the design of ePCTs.
Watch the Webinar